Koers BrainsWay Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
BWAY
IL0011007189
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 37,78 mln. 143 mln. 35,25 mln. | Omzet 2025 * | 44,04 mln. 167 mln. 41,09 mln. | Marktkapitalisatie | 85,62 mln. 324 mln. 79,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 0 | Nettowinst (verlies) 2025 * | 2 mln. 7,56 mln. 1,87 mln. | EV/omzet 2024 * | 2,27 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,94 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,14% |
Recentste transcriptie over BrainsWay Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hadar Levy
CEO | Chief Executive Officer | 52 | 14-09-14 |
Yiftach Roth
FOU | Founder | 54 | 01-05-06 |
David Zacut
FOU | Founder | 72 | 07-11-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Josef Ben Shalom
BRD | Director/Board Member | 68 | 01-12-18 |
Karen Sarid
BRD | Director/Board Member | 73 | 03-12-17 |
Amiram Boehm
CHM | Chairman | 52 | 12-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,78% | 220 mld. | |
+8,24% | 185 mld. | |
+11,16% | 133 mld. | |
+26,12% | 107 mld. | |
+0,19% | 62,91 mld. | |
+16,21% | 53,34 mld. | |
-1,63% | 47,71 mld. | |
-1,11% | 40,29 mld. | |
+12,16% | 39,57 mld. |